Skip to content

PAR-25-135 NCI K99 eligibility Guide

Updated 8 official sources

Quick Answer: PAR-25-135 is the active NCI K99/R00 Pathway to Independence route for cancer postdocs who need mentored K99 support before moving to an independent R00 phase and are not proposing to lead an independent clinical trial.

Full answer and how we checked it

The October 14, 2026 receipt date has passed; two more follow in 2027 (February 17 and June 15) before NIH retires the current K announcements by July 13, 2027. The decision turns on 7 checks.

Who this is for: Cancer postdocs, physician-scientists, mentors, department chairs, training offices, and sponsored-research teams deciding whether the no-trial NCI K99/R00 is the right route.

Data note: This guide uses NIH PAR-25-135, NIH PAR-25-313, the NCI K99/R00 program page, Grants.gov listing 357259, NIH notices NOT-OD-26-098 and NOT-OD-26-120, and USAspending data, checked again on October 9, 2026.

In this guide

According to NIH in PAR-25-135 (opens in a new tab), this route helps postdoctoral researchers with clinical or research doctorates move from mentored postdoctoral positions to independent, tenure-track or equivalent faculty positions. NIH also says this NOFO is for candidates whose work does not involve leading an independent clinical trial.

The decision question is not just "Is the candidate strong?" The real question is whether the candidate is still eligible, can justify further mentored development, and can show a distinct R00 research program.

Use this guide with the live NCI K99/R00 clinical trial not allowed program record. Then compare NCI K99 Clinical Trial Required guide, NCI R25 Courses guide, NIH grants complete guide, NIH R01 R21 R03 K awards comparison, NIH K99/R00 pathway guide, NCI payline guide, what is a NOFO, and the Grantsights grant database.

Source Check

Checked October 2026.

According to NIH in PAR-25-135 (opens in a new tab), this NCI K99/R00 route remains active. The October 14, 2026 receipt date has passed, so the next receipt date is February 17, 2027, followed by June 15, 2027, with 5 p.m. local-time submission. The NOFO itself still lists an October 14, 2027 date and an October 15, 2027 expiration, but NIH notice NOT-OD-26-098 (opens in a new tab) (August 12, 2026) says any active NOFO using the current K activity codes will be expired by July 13, 2027. K99 applications due on or after October 12, 2027 move to a new KT1/R00 parent announcement. Candidates who submitted on October 14 should expect review in March 2027, council in May 2027, and a K99 start no earlier than July 2027. NIH says this route is clinical trial not allowed, but candidates may gain experience in a mentor-led clinical trial when they are not leading it.

According to the NCI K99/R00 award page (opens in a new tab), NCI no longer participates in the parent K99/R00 announcements. NCI says applicants must use PAR-25-135 for no-trial applications or PAR-25-313 (opens in a new tab) when the candidate will lead an independent clinical trial. That second option is ending: NOT-OD-26-098 (opens in a new tab) says NIH will no longer support "Independent Clinical Trial Required" K announcements, and K award funds may not pay for conducting a clinical trial. K awardees can still gain trial experience in a trial led by a mentor or co-mentor, and candidates who want to lead a trial as PI must find separate funding.

One change helps February and June 2027 applicants. NIH notice NOT-OD-26-120 (opens in a new tab) (October 5, 2026) says Data Management and Sharing Plans are no longer required for any K award application, effective immediately, and NIH won't treat a missing DMS Plan as noncompliant.

October 2026 checkCurrent source readApplicant action
StatusActive, but NIH expires current K announcements by July 13, 2027Use the NCI-specific announcements for the February 2027 or June 2027 dates
Next receiptFebruary 17, 2027 (October 14, 2026 has passed)Check whether the candidate clock allows the February or June 2027 cycle
Trial boundaryCandidate cannot lead an independent trialPAR-25-313 covers candidate-led trials only until it expires; future K awards can't fund trial conduct
Postdoc windowNo more than 6 years at initial or resubmission applicationCalculate leave and extension facts before writing
NCI routingParent K99 is not an NCI pathDo not submit to a parent K99 notice for NCI
DMS PlanNot required for K applications (NOT-OD-26-120 (opens in a new tab))Drop the DMS Plan from the 2027 package

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

7 PAR-25-135 Eligibility Stop Checks

Stop checkStrong PAR-25-135 signalRed flag
Candidate stageMentored postdoc, not independentFaculty or non-mentored research role
ExperienceNo more than 6 years postdoctoral researchOver the limit
Trial statusNo independent clinical trialCandidate leads a trial
K99 needFurther mentored development is justifiedCandidate is already ready
Cancer fitNCI mission is directWeak cancer relevance
R00 planIndependent research program is clearMentor project continues
Award historyNo disqualifying PI historyPrior major independent award

K99 decisions go wrong when teams treat this as a prestige award instead of a timing and independence test.

5 Source Facts Applicants Should Know

According to NIH in PAR-25-135 (opens in a new tab), the activity code is K99/R00, clinical trials are not allowed, and the total project period may not exceed 5 years. NIH states that candidates must have no more than 6 years of postdoctoral research experience at initial application or later resubmission.

According to the NCI K99/R00 award page (opens in a new tab), NCI no longer participates in parent K99/R00 announcements and NCI K99/R00 applications must use PAR-25-135 or PAR-25-313. According to USAspending.gov (opens in a new tab) data, Assistance Listing 93.398 (Cancer Research Manpower) had about $216.8 million in FY2024 grant obligations. That listing covers all NCI training and career awards, not just the K99/R00.

FactSource-backed read
Funding numberPAR-25-135
MechanismK99/R00 career transition award
Clinical trial statusNot allowed
Candidate windowNo more than 6 years postdoctoral experience
Next receipt dateFebruary 17, 2027 (October 14, 2026 has passed)
Last receipt date under this NOFOJune 15, 2027
ExpirationBy July 13, 2027, per NOT-OD-26-098 (the NOFO still lists October 15, 2027)
DMS PlanNo longer required for K applications (NOT-OD-26-120)

What NCI Doesn't Tell You

Within 21 days, answer 4 practical questions. First, the candidate cannot be too independent. NIH says applications from candidates in independent or non-mentored positions are nonresponsive.

Second, no-trial status does not mean no human work. A candidate may gain experience in a mentor-led clinical trial, but the candidate cannot propose to lead an independent clinical trial under this route.

Third, the R00 plan must separate from the mentor. Don't submit if the independent phase looks like a renamed mentor project.

Fourth, timing matters. A candidate near the 6-year limit needs resubmission math before they build a full application.

The 6-Year Clock, Titles, and Prior Awards

Eligibility is decided by 3 tests before reviewers see the science. The clock counts only research time: NIH says candidates must have no more than 6 years of postdoctoral research experience as of the relevant due date, whether the application is new or a resubmission.

Eligibility questionWhat PAR-25-135 (opens in a new tab) says
What counts toward 6 yearsOnly time spent on research; part-time research is prorated
What does not countParental, medical, military, or other justified leave generally under 12 months, and clinical training with no research
ChildbirthNCI approves a one-year extension; send the child's date of birth to an NCI program official
Disqualifying titlesResearch assistant professor or assistant professor; these applications are withdrawn
Disqualifying awardsPrior independent PD/PI on an NIH R01, R03, or R21, an NIH K01, K07, K08, K23, or K25, or another peer-reviewed grant over $100,000 direct costs a year
CitizenshipNot required; for a temporary visa holder, the institution documents that the visa covers the K99 phase
EffortAt least 9 person-months, or 75% of full-time effort

Independence timing is the trap. If a candidate takes any faculty or non-mentored research position before the K99 is awarded, NIH issues neither the K99 nor the R00. A candidate interviewing for faculty jobs while the application is pending should talk to NCI program staff first.

Award Money in Each Phase

The two phases are funded very differently, and the R00 budget is a total-cost figure.

ItemK99 mentored phaseR00 independent phase
LengthUp to 2 yearsUp to 3 years
SalaryNCI contributes up to $100,000 a year, plus fringeIncluded in the R00 total
Research and development costsUp to $30,000 a yearIncluded in the R00 total
Total capSalary plus research costs aboveUp to $249,000 a year, including indirect costs
Indirect costs8% of modified total direct costsThe R00 institution's rate
Mentor or administrative salaryNot allowedNot allowed

Because the R00 cap includes indirect costs, a candidate moving to an institution with a high indirect rate gets less research money from the same $249,000. That is worth knowing before negotiating a start-up package.

Reference Letters, Mentor Statements, and the R00 Transition

Two parts of the application come from other people, and both can stop it. Reference letters go through the eRA Commons referee link, not Grants.gov, and NIH does not review an application missing its required letters. The primary mentor's statement must cover supervision plans, a commitment to annual progress evaluations, and help with the job search and R00 application. When the candidate gains experience in a mentor-led clinical trial, the mentor must also document that they lead the trial.

The R00 is not automatic. The NCI K99/R00 award page (opens in a new tab) says the candidate must accept a tenure-track, full-time assistant professor position or equivalent, and the new institution submits the R00 application at least 2 months before the planned activation date. NCI also requires the R00 institution to protect 75% research effort, not use R00 funds to offset a normal start-up package, and confirm that the appointment does not depend on the award transferring. NIH says R00 awards generally go only to candidates who accept such a position by the end of the K99 period.

6 Evidence Assets That Make This K99/R00 Stronger

Within 21 days, build 6 evidence assets. Asset 1 is the candidate timeline: doctoral degree, postdoctoral start, leave periods, childbirth extension if relevant, and expected submission dates.

Asset 2 is the independence memo. It should list current title, appointment terms, PI authority, prior awards, and whether the candidate can already apply as an independent investigator.

Asset 3 is the no-trial memo. State whether the project has human participants, whether the candidate leads any trial activity, and whether the work belongs under PAR-25-135 or PAR-25-313. Remember that PAR-25-313 expires by July 13, 2027, and NIH says future K awards won't pay for conducting a trial.

Asset 4 is the mentored-development plan. Include training gaps, mentors, milestones, and why further mentored K99 support is needed.

Asset 5 is the R00 one-pager. It should read like a future lab program with its own question, resources, protected time, and NCI mission fit.

Asset 6 is the route comparison. Compare PAR-25-135 with PAR-25-313, parent K99 paths, K08, K23, R21, and early R01 options.

5 Route Choices Before Drafting

Within 21 days, compare 5 routes.

RouteBetter first read when...Why
PAR-25-135Candidate does not lead a clinical trialRoute fits
PAR-25-313Candidate proposes an independent clinical trial and can apply before it expires by July 13, 2027Companion route fits for now
K08 or K23Clinician training needs differOther K route may fit
R21 or R01Candidate is already independentCareer award may be wrong
Institutional bridgeTiming or title blocks K99Local route may fit

The strongest application explains why this award, this candidate, and this timing line up.

6 Bad-Fit Signals

First, the candidate is already independent. Second, the candidate exceeds the 6-year postdoctoral window. Third, the candidate will lead an independent clinical trial.

Fourth, the research plan duplicates the mentor's aims. Fifth, the candidate has disqualifying independent PI history. Sixth, the R00 institution plan is vague.

Those stop checks help users avoid a career-award path that can fail before peer review.

21-Day K99/R00 Readiness Plan

Days 1 through 3 should confirm the candidate clock, current title, prior awards, trial status, and deadline. Days 4 through 7 should write the no-trial and independence memos.

Days 8 through 12 should build the training plan and mentor table. Days 13 through 16 should draft the R00 program. Days 17 through 21 should compare PAR-25-135, PAR-25-313, K08/K23, R21/R01, and bridge options.

6 Final Research Checks Before Submission

Within 21 days, finish 6 final research checks. Check 1 is the current NIH notice. Check 2 is the NCI K99 page because NCI now routes applicants through its own K99 announcements. Check 3 is the candidate's postdoctoral clock. Check 4 is no-trial status. Check 5 is mentor overlap. Check 6 is the R00 job-market plan.

You're ready when the candidate can explain why PAR-25-135 is better than the clinical-trial-required path and why the R00 phase will be independent.

4 Public Decision Questions For Candidates

Within 21 days, ask 4 public decision questions. Question 1: "Are you still in a mentored postdoctoral role?" Question 2: "Are you within the 6-year postdoctoral window?" Question 3: "Are you avoiding candidate-led independent clinical trials?" Question 4: "Can the R00 plan stand apart from the mentor's work?"

If the answer to any of these is unclear, talk to NCI program staff before drafting. The answers should show that eligibility, trial status, mentor overlap, and independence are all separate gates.

7 Route Checks

Added June 2, 2026.

Checked on June 2, 2026 against PAR-25-135 (opens in a new tab), the NCI K99 page (opens in a new tab), the Grants.gov listing (opens in a new tab), PAR-25-313 (opens in a new tab), and USASpending.gov (opens in a new tab).

CheckPublic answer
EligibilityConfirm the applicant, institution, and route rules for PAR-25-135 NCI K99 eligibility.
Source statusVerify the official listing, notices, due date, and expiration status, including NOT-OD-26-098.
BudgetCheck award size, cost limits, match, or budget logic when the source provides it.
EvidenceName the data, preliminary work, partner role, or implementation proof needed.
Bad fitStop if the project belongs in a nearby NCI or federal route.
Review criteriaTie the first page to significance, approach, team, environment, and source-specific criteria.
Next actionDecide whether to draft for the February or June 2027 date, ask a program contact, redirect, or wait for the KT1/R00 parent announcement.

Final public checklist

  • Confirm whether K99 is the right route or whether a nearby program fits better.
  • Check budget, partner, match, or data-readiness constraints.

Sources

Next steps

Where to go next

These next pages help you move from research into a specific grant choice.

Frequently Asked Questions

What does PAR-25-135 fund?

It supports NCI K99/R00 career transition awards for postdoctoral researchers who are not proposing to lead an independent clinical trial.

Are clinical trials allowed?

No. PAR-25-135 is clinical trial not allowed, though a candidate may gain experience in a mentor-led clinical trial.

What postdoctoral time limit applies?

Candidates must have no more than 6 years of related postdoctoral research experience at initial application or resubmission.

What is the next 2026 deadline?

The October 14, 2026 receipt date has passed. February 17, 2027 is the next receipt date for new and resubmission applications, followed by June 15, 2027. NIH notice NOT-OD-26-098 says current K announcements, including this one, will expire by July 13, 2027; K99 applications due on or after October 12, 2027 move to a new KT1/R00 parent announcement.

Who should skip this route?

Skip it if the candidate is already independent, will lead an independent clinical trial, or lacks a clear R00 independence plan.

Last updated October 9, 2026. Corrected October 9, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.